NCT06788678

Brief Summary

Despite the availability of evidence-based treatments for PTSD, there are many challenges to successful trauma recovery for Veterans including difficulties starting and completing these treatments and gaps in fully addressing additional important treatment targets including lower social functioning and quality of life. Alternative, stand-alone treatment options that address a range of outcomes and can be easily accessed are needed to expand the reach of PTSD treatment to Veterans. One way to address this need is with a positive psychology intervention called MOVED, which has shown promise in a prior pilot study. MOVED is a web-based, self-guided intervention (8 sessions, 4 weeks) that uses moral elevation-feeling inspired by others' virtuous actions. This clinical trial will test if MOVED leads to decreased PTSD symptoms and increased social functioning and quality of life compared to a generic supportive treatment that does not focus on moral elevation. Results will help determine if MOVED is a useful alternative approach to target trauma recovery among Veterans with PTSD.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
41mo left

Started Jun 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 23, 2025

Completed
1.4 years until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2029

3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2029

Last Updated

May 6, 2026

Status Verified

May 1, 2026

Enrollment Period

3.1 years

First QC Date

January 17, 2025

Last Update Submit

May 5, 2026

Conditions

Keywords

PTSDWeb-Based InterventionVeteransRandomized Controlled TrialMoral Elevation

Outcome Measures

Primary Outcomes (3)

  • Clinician Administered PTSD Scale for DSM-5 (CAPS-5)

    The CAPS-5 is a 30-item structured interview that will be used to assess clinician-rated PTSD symptom severity (range = 0-80).

    Follow-up assessments at posttreatment, 3-months, and 6-months.

  • World Health Organization Quality of Life - Brief Version (WHOQOL-BREF)

    The WHOQOL-BREF is a 26-item self-report measure that will be used to assess overall quality of life with 4 domains (physical health, psychological health, social relationships, and environment). Subscales scores are computed by summing all items for each subscale, then all scores are transformed to a range of 0-100. A higher score signifies higher or better quality of life.

    Follow-up assessments at posttreatment, 3-months, and 6-months.

  • World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)

    The WHODAS 2.0 is a self-report measures of functioning. Two socially-oriented subscales comprised of 13 items total will be used to assess social functioning across the Getting Along and Participation domains. Higher scores indicate greater functioning.

    Follow-up assessments at posttreatment, 3-months, and 6-months.

Secondary Outcomes (5)

  • PTSD Checklist for DSM-5 (PCL-5)

    Follow-up assessments at posttreatment, 3-months, and 6-months.

  • Moral Injury and Distress Scale (MIDS)

    Follow-up assessments at posttreatment, 3-months, and 6-months.

  • Engagement with Beauty Scale (EBS) - Moral Beauty Subscale

    Follow-up assessments at posttreatment, 3-months, and 6-months.

  • Purpose in Life - Short Form (PIL-SF)

    Follow-up assessments at posttreatment, 3-months, and 6-months.

  • Posttraumatic Growth Inventory (PTGI)

    Follow-up assessments at posttreatment, 3-months, and 6-months.

Other Outcomes (1)

  • State Moral Elevation Scale (SMES)

    Administered during 8 sessions across 4 weeks

Study Arms (2)

MOVED

EXPERIMENTAL

Moral Elevation Online Intervention for Veterans Experiencing Distress.

Behavioral: MOVED

Supportive Care Control

ACTIVE COMPARATOR

Present-centered, nondirective intervention

Other: Supportive Care Control

Interventions

MOVEDBEHAVIORAL

MOVED includes 8 self-guided, web-based sessions administered over 4 weeks. Web-based sessions include 3 core components: (1) elicit moral elevation, (2) engage in reflection about moral elevation response, and (3) set a behavioral goal that is inspired by the moral elevation exercise.

Also known as: Moral Elevation Online Intervention for Veterans Experiencing Distress
MOVED

A present-centered, nondirective intervention that aims to control for the nonspecific therapeutic effects of supportive care. In this case, the effects of engaging in regular web-based sessions that convey information about PTSD symptoms. Sessions will include psychoeducation materials about PTSD symptoms, functioning, and resources for dealing with related stressors. Key components of MOVED will be strictly excluded.

Supportive Care Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Enrolled in a VISN 17 health care system
  • English-speaking and able to provide written informed consent
  • Willingness to complete study procedures and be randomized
  • Internet access and an electronic device to complete the web-based sessions
  • Current diagnosis of PTSD based on the CAPS-5
  • History of PTSD diagnosis for at least 1 year

You may not qualify if:

  • History of severe traumatic brain injury indicated by medical record review and the Ohio State Traumatic Brain Injury Identification Method (OSU TBI-ID)
  • Current psychosis or mania as indicated by medical record review and the Mini International Neuropsychiatric Interview (MINI)
  • Current suicide risk based on the Beck Depression Inventory-II (BDI-II)
  • Currently enrolled and actively participating in a trauma-focused treatment including:
  • Cognitive Processing Therapy
  • Prolonged Exposure
  • Eye Movement Desensitization Reprocessing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Central Texas Veterans Health Care System, Temple, TX

Temple, Texas, 76504-7451, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Adam P. McGuire, PhD

    Central Texas Veterans Health Care System, Temple, TX

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Adam P McGuire, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
All staff conducting baseline and follow-up assessments (i.e., posttreatment, 3-months, 6-months) will be blinded to the assigned condition for all participants.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomized to either the MOVED condition (target intervention) or a Supportive Care Control (SCC) condition. Both conditions are accessed through an online portal. The MOVED condition includes the moral elevation treatment with intervention content and goal setting activities. The SCC condition is a present-centered, nondirective interaction that aims to control for the nonspecific therapeutic effects of engaging in regular web-based session. Specifically, it includes psychoeducation materials about PTSD symptoms, functioning, and resources for related stressors. Key intervention components of MOVED (e.g., moral elevation exercises and goal-setting) will be excluded from SCC.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 17, 2025

First Posted

January 23, 2025

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

June 30, 2029

Study Completion (Estimated)

September 30, 2029

Last Updated

May 6, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

A de-identified, anonymized dataset will be created and shared pursuant to a Data Use Agreement (DUA).

Time Frame
1 year after publication

Locations